These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1901649)

  • 1. Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.
    Takeyama M; Ishida T; Kokubu N; Komada F; Iwakawa S; Okumura K; Hori R
    Pharm Res; 1991 Jan; 8(1):60-4. PubMed ID: 1901649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF.
    Okumura K; Kiyohara Y; Komada F; Iwakawa S; Hirai M; Fuwa T
    Pharm Res; 1990 Dec; 7(12):1289-93. PubMed ID: 2128896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
    Ino Y; Suzuki K; Sato T; Iwaki M
    Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic effects of epidermal growth factor (EGF) ointment containing protease inhibitor or gelatin in rats with burns or open wounds.
    Kiyohara Y; Komada F; Iwakawa S; Fuwa T; Okumura K
    Biol Pharm Bull; 1993 Jan; 16(1):73-6. PubMed ID: 8369756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans.
    Hori R; Komada F; Iwakawa S; Seino Y; Okumura K
    Pharm Res; 1989 Sep; 6(9):813-6. PubMed ID: 2682592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of synthetic protease inhibitor on the sphincter of Oddi function in dogs].
    Matsumura T; Yada S; Miyoshi Y; Komi N
    Nihon Shokakibyo Gakkai Zasshi; 1991 Oct; 88(10):2663-70. PubMed ID: 1758083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium.
    Sendo T; Itoh Y; Goromaru T; Sumimura T; Saito M; Aki K; Yano T; Oishi R
    Br J Pharmacol; 2003 Mar; 138(5):959-67. PubMed ID: 12642398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a small molecular weight proteinase inhibitor, gabexate mesilate (FOY), on insulin receptor function in vitro.
    Göke R; Göke B; Steinfelder HJ; Arnold R
    Int J Pancreatol; 1988 Mar; 3(2-3):135-42. PubMed ID: 3129526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
    Keck T; Balcom JH; Antoniu BA; Lewandrowski K; Warshaw AL; Fernández-del Castillo CF
    Surgery; 2001 Aug; 130(2):175-81. PubMed ID: 11490346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoprotective effects of epidermal growth factor (EGF) ointment containing nafamostat, a protease inhibitor, on tissue damage at burn sites in rats.
    Kiyohara Y; Nishiguchi K; Komada F; Iwakawa S; Hirai M; Okumura K
    Biol Pharm Bull; 1993 Nov; 16(11):1146-9. PubMed ID: 8312873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
    Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
    Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood viscosity with synthetic protease inhibitors.
    Hitosugi M; Niwa M; Takahashi T; Kurosu A; Nihei H; Nagai T; Tokudome S
    J Pharmacol Sci; 2003 Apr; 91(4):334-6. PubMed ID: 12719663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in wound healing by epidermal growth factor (EGF) ointment. II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burn.
    Kiyohara Y; Komada F; Iwakawa S; Hirai M; Fuwa T; Okumura K
    J Pharmacobiodyn; 1991 Jan; 14(1):47-52. PubMed ID: 1861238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of synthetic protease inhibitors on superoxide (O2-), hydrogen peroxide (H2O2) and hydroxyl radical production by human polymorphonuclear leukocytes.
    Tamura K; Manabe T; Imanishi K; Nonaka A; Asano N; Yamaki K; Tobe T
    Hepatogastroenterology; 1992 Feb; 39(1):59-61. PubMed ID: 1314767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nafamostat mesilate is an extremely potent inhibitor of human tryptase.
    Mori S; Itoh Y; Shinohata R; Sendo T; Oishi R; Nishibori M
    J Pharmacol Sci; 2003 Aug; 92(4):420-3. PubMed ID: 12939527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
    Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
    Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
    Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
    Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
    Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
    Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
    Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.